Asymmetric dimethylarginine: A molecule responsible for the coexistence of insulin resistance and atherosclerosis via dual nitric oxide synthase inhibition
- 1 January 2005
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 65 (6), 1091-1098
- https://doi.org/10.1016/j.mehy.2005.07.001
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Insulin sensitivity is mediated by the activation of the ACh/NO/cGMP pathway in rat liverAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2004
- Impaired insulin sensitivity is an independent predictor of common carotid intima-media thickness in a population sample of elderly menAtherosclerosis, 2003
- Hepatic insulin sensitizing substance: a novel ‘sensocrine’ mechanism to increase insulin sensitivity in anaesthetized ratsBritish Journal of Pharmacology, 2003
- The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA)Clinical Nutrition, 2003
- Arterial Wall Thickness is Associated with Insulin Resistance in Type 2 Diabetic PatientsJournal of Atherosclerosis and Thrombosis, 2003
- Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.Diabetes Care, 2000
- Insulin Resistance Contributes to Carotid Arterial Wall Thickness in Patients with Non-Insulin-Dependent-Diabetes Mellitus.Endocrine Journal, 1999
- Insulin Resistance as an Independent Risk Factor for Carotid Wall ThickeningHypertension, 1996
- Carotid Artery Wall Intima-Media Thickness Is Associated With Insulin-Mediated Glucose Disposal in Men at High and Low Coronary RiskStroke, 1995
- Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failureThe Lancet, 1992